A study of serum biomarkers associated with relapse of cervical cancer

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4913-4922

  Mordhorst, Louise Bohr ^a   Sorbe, Bengt ^a   Ahlin, Cecilia ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biomarkers; Cervical cancer; Local control; Proteomics; Recurrences

Indexed keywords

CISPLATIN; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

AGED; AREA UNDER CURVE; FEMALE; HUMANS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROTEIN ARRAY ANALYSIS; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84872659639     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parikh S, Brennan P and Boffetta P: Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 105: 687-691, 2003.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD and Murray CJ: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378: 1461-1484, 2011.
3. Cancer incidence in Sweden, 2010. Official Statistics of Sweden. Statistics - Health and Medical Care. ISSN 1400-3511. Socialstyrelsen, Stockholm, 2011.
4. Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray MF and Podratz KC: Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35: 130-135, 1989.
5. Perez CA, Grigsby PW, Nene SM, Camel HM, Galakatos A and Kao MS: Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69: 2796-2806, 1992.
6. Thoms WW Jr, Eifel PJ, Smith TL, Morris M, Delclos L and Wharton JT: Bulky endocervical carcinoma: A 23-year experience. Int J Radiat Oncol Biol Phys 23: 491-499, 1992.
7. Chemoradiotherapy for cervical cancer meta-analysis collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis. Cochrane Database of Systematic Reviews 2010. Issue 1. Art. No.: CD008285. DOI: 10.1002/14651858. CD 008285.
8. Burger RA: Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies. J Gynecol Oncol 21: 3-11, 2010.
9. Jr GW, Cazares LH, Leung SM, Nasim S, Adam BL and Yip TT: ProteinChip (R) surface-enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 5/6: 264-276, 1999.
10. Hutchens TW and Yip TT: New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7: 576-580, 1993.
11. Xia T, Zheng ZG, Mou HZ, Xu SH, Zhang P and Zhu JQ: Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma. Ai Zheng 27: 279-282, 2008.
12. Liu C, Pan C, Shen J, Wang H, Yong L and Zhang R: Discrimination analysis of mass spectrometry proteomics for cervical cancer detection. Med Oncol Suppl 1: S 553-559, 2011.
13. Liu H, Han Y, Mi R, Zhang Y, Su G and Wang H: Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients. Int J Gynecol Cancer 21: 1452-1457, 2011.
14. Zaino RJ, Ward S, Delgado G, Bundy B, Gore H and Fetter G: Histopathologic predictors of the behaviour of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 69: 1750-1758, 1992.
15. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE and Fowler WC: Carcinoma of the cervix treated with radiation therapy. I. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67: 2776-2785, 1991.
16. Hagemann T, Bozanovic T, Hooper S, Ljubic A, Slettenaar VI and Wilson JL: Molecular profiling of cervical cancer progression. Br J Cancer 96: 321-328, 2007.
17. Atahan K, Gür S, Yiǧitbaşi T, Baskin Y, Yiǧit S and Deniz M: The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer. Int J Med Sci 12: 148-155, 2001.
18. Laronga C and Drake RR: Proteomic approach to breast cancer. Cancer Control 14: 360-368, 2007.
19. Yuan Y, Tan CW, Shen H, Yu JK, Fang XF and Jiang WZ: Identification of the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer patients using SELDI-TOF-MS and artificial neural networks. Hepatogastroenterology 59(120).doi:10.5754/he 12127. [Epub ahead of print].
20. Fan NJ, Gao CF and Wang XL: Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterol Res Pract Epub 2011, Dec 29; 2011: 784967. [Epub ahead of print].
21. Jia L, Zhang H, Qu X, Deng B and Kong B: Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer. Med Hypotheses 78: 407-409, 2012.
22. Higareda-Almaraz JC, del Rocio Enriquez-Gasca M, Hernandesz-Ortiz M, Resendis- Antonio O, and Encamación-Guevara S: Proteomic patterns of cervical cancer cell lines, a network perspective. BMC Syst Biol 5: 2011, June 22; doi: 10.1186/1752-0509-5-96 [Epub ahead of print].
23. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ and Ahn WS: Tow-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99: 26-35, 2005.
24. Lomnytska MI, Becker S, Hellman K, Hellström AC, Souchelnytskyi S, Mints M, Hellman U, Andersson S and Auer G: Diagnostic protein marker patterns in squamous cervical cancer. Proteomics Clin Appl 4: 17-31, 2010.